Skip to content

Clinical trials

Phase 3 Polycythemia Vera trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycythemia Vera Phase: Phase 3 Country / region: Australia Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20142
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CTI BioPharma2
Incyte Corporation1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Ono Pharmaceutical Co., Ltd.1
Protagonist Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycythemia Vera7
Bone Marrow Diseases3
Hematologic Diseases3
Myeloproliferative Disorders3
Primary Myelofibrosis3
Thrombocythemia, Essential3
Anemia2
Splenomegaly2
Thrombocytopenia2
Hemorrhagic Disorders1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.